Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aflac Incorporated
Aflac Incorporated Announces Third Quarter Results, Reports Net Earnings Decline Due to Realized Investment Losses, Produces 20.0% Increase in Operating EPS
November 7th, 2008
Aflac Incorporated reported its third quarter results. Total revenues declined 4.4% to $3.7 billion during the third quarter of 2008 due to realized investment losses, compared with $3.9 billion in the third quarter of 2007. Net earnings were $100 million, or $.21 per diluted share, compared with $420 million, or $.85 per share, a year ago. Net earnings in the third quarter included realized investment losses of $389 million, or $.81 per diluted share, compared with a realized investment gain of $1 million, or nil per diluted share in the third quarter of 2007. Approximately $198 million of the after-tax investment losses in the third quarter...
Source: Health Business Week (2008-11-07)
|
